Clinical Trials Logo

Stomatitis clinical trials

View clinical trials related to Stomatitis.

Filter by:

NCT ID: NCT04382079 Recruiting - Oral Mucositis Clinical Trials

Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial

Start date: April 8, 2020
Phase: N/A
Study type: Interventional

The investigators plan to conduct a 3-year pioneering care research project for mucositis in cancer patients. These include: (1) an analysis of the incidence and severity of mucositis, severity, treatment methods, and treatment costs; (2) an RCT comparing the effectiveness of honey, Taiwan green propolis, and usual care in mucositis of cancer patients; (3) monitoring of related symptom changes using a smart bracelet device; (4) a measurement of IL-1, IL-6, IL-10, and TNF in saliva and (4) modeling of the trend of mucositis for alertness and search of essential parameters of the complications.

NCT ID: NCT04321850 Terminated - Oral Mucositis Clinical Trials

Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.

Start date: June 10, 2019
Phase: N/A
Study type: Interventional

Oral mucositis (OM) is a secondary complication of chemo/radiotherapy, which causes pain, dysphagia and predisposition to infections, being a frequent reason for hospitalization that may have an impact on the prognosis of cancer patients. Various interventions for the prevention of OM have been studied, including the use of zinc, which is a micronutrient that participates in various cellular functions and in wound repair, while showing a reduction in the incidence and severity of MO, so the purpose of the present study is to evaluate the impact of the use of zinc in the prevention of oropharyngeal mucositis in pediatric patients with acute lymphoblastic leukemia in chemotherapy, comparing it with the use of placebo. Hypothesis: The use of zinc reduces the incidence and severity of OM in pediatric patients with ALL in chemotherapy compared to the control group.

NCT ID: NCT04317183 Recruiting - Clinical trials for Oral Mucositis Due to Chemotherapy

Topical Chamomile in Preventing Chemotherapy-induced Oral Mucositis

Start date: May 15, 2019
Phase: Phase 2
Study type: Interventional

the main aim of this study is to clinically assess the effectiveness of topical chamomile oral gel in the prevention of chemotherapy-induced oral mucositis.

NCT ID: NCT04308161 Recruiting - Clinical trials for Oral Mucositis Due to Radiation

Vitamin D Oral Gel for Prevention of Radiation Induced Oral Mucositis

Start date: November 2, 2019
Phase: Phase 2
Study type: Interventional

The main aim of this study was to evaluate clinically the effect of topical oral vitamin D gel in comparison to conventional therapy in prevention of radiation - induced oral mucositis

NCT ID: NCT04303312 Not yet recruiting - Mucositis Oral Clinical Trials

Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis

Start date: December 2021
Phase: Phase 3
Study type: Interventional

Oral mucositis consequences can range from pain, decreased oral intake, impaired speech and swallowing to adverse events as severe as septicemia, increased hospitalization, and G-tube feeding A wide variety of agents have been tested to prevent OM or reduce its severity.This trial will assess the usefulness of solcoseryl and pumpkin seed oil versus Benzydamine Hydrochloride mouth wash in management of oral mucositis in patients receiving radiotherapy and/or chemotherapy.

NCT ID: NCT04292990 Not yet recruiting - Pain Clinical Trials

Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients

Start date: December 2020
Phase: Phase 4
Study type: Interventional

The primary purpose of this study is to explore the significance of analgesic treatment for radiation-induced oral mucositis pain in patients with nasopharyngeal carcinoma during radiotherapy, and to compare the analgesic effect of morphine controlled-release tablets with that of fentanyl transdermal patch. Half of participants will receive morphine controlled-release tablets,while the other half will receive fentanyl transdermal patch.

NCT ID: NCT04265001 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.

Start date: November 1, 2019
Phase: Phase 3
Study type: Interventional

This study was conducted to estimate the hypothesis that the topical hyaluronic acid mouthwash have no role in the treatment of recurrent aphthous stomatitis

NCT ID: NCT04227340 Completed - Oral Mucositis Clinical Trials

Prevention of Oral Mucositis Using Photobiomodulation Therapy

Start date: February 4, 2020
Phase: N/A
Study type: Interventional

Oral mucositis is a significant and common toxicity experienced by patients who receive high-dose chemotherapy as a preparatory regimen for a hematopoietic cell transplant (HCT). Furthermore, oral mucositis has been reported as the single most debilitating side effect reported by patients undergoing HCT. The incidence of HCT mucositis among adults is estimated to range between 76% and 89%; however, comparisons are difficult due to variability in patient ages, treatments and criteria for scoring oral mucositis. The use of intra-oral photobiomodulation (PBM) therapy in adult patients after the development of oral mucositis is well documented and now included in the international mucositis guidelines, with limited evidence in pediatrics. This study will build evidence for the incorporation of extra-oral PBM therapy into daily nursing care of children and adolescents undergoing HCT. This intervention has potential in providing evidence for efficacy in the prevention and treatment of oral mucositis, the single most debilitating side effect reported by patients undergoing HCT. Primary Objective: - To evaluate feasibility and efficacy of photobiomodulation therapy (PBM) in reducing oral mucositis in children and adolescents at risk for grade 3 oral mucositis undergoing an allogeneic hematopoietic cell transplant (HCT). Secondary Objective: - To compare clinical manifestations associated with the development of oral mucositis between those treated with daily PBM and a matched control. Clinical factors to include: grade and duration or oral mucositis. Exploratory Objective: - To evaluate efficacy of photobiomodulation therapy in autologous patients at risk for grade 3 oral mucositis compared to matched control. - To evaluate utilization of play-based procedural preparation and treatment feasibility and parental satisfaction.

NCT ID: NCT04227314 Not yet recruiting - Clinical trials for Recurrent Aphtous Stomatitis

Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis

PREMS
Start date: January 2022
Phase: Phase 3
Study type: Interventional

The objective of the study is to assess the superiority of apremilast in comparison with placebo to achieve Complete Remission (CR) of oral ulcers at Week 12, in patients with severe Recurrent aphtous stomatitis resistant or intolerant to colchicine.

NCT ID: NCT04204382 Recruiting - Clinical trials for Radiation-induced Oral Mucositis

Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer

Start date: December 12, 2019
Phase: Phase 4
Study type: Interventional

Oral mucositis (OM) is an acute side effect of radiotherapy for head and neck cancer (HNC). OM associated pain affects oral functions and nutrition of the patient that may result in discontinuity of treatment.The purpose of this clinical study is to evaluate the therapeutic effects of Compound Kushen Injection (CKI) on oral mucositis caused by radiotherapy of head and neck cancer.